Nuvalent (NASDAQ:NUVL) Shares Gap Up to $15.04
Nuvalent (NASDAQ:NUVL) Shares Gap Up to $15.04
Nuvalent, Inc. (NASDAQ:NUVL – Get Rating)'s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $15.04, but opened at $15.55. Nuvalent shares last traded at $16.64, with a volume of 1,045 shares changing hands.
新价公司(纳斯达克代码:NUVL-GET Rating)的股价在周三开盘前大幅上涨。该股此前收于15.04美元,开盘报15.55美元。新价公司的股票最新报16.64美元,成交量为1,045股。
Analyst Upgrades and Downgrades
分析师升级和下调评级
Separately, BMO Capital Markets started coverage on Nuvalent in a report on Thursday, June 23rd. They set an "outperform" rating and a $28.00 price target for the company.
另外,蒙特利尔银行资本市场在6月23日星期四的一份报告中开始对Nuvalal进行报道。他们为该公司设定了“跑赢大盘”的评级和28.00美元的目标价。
Nuvalent Stock Up 13.0 %
新价股票上涨13.0%
The stock has a market cap of $821.27 million, a P/E ratio of -11.45 and a beta of 1.12. The business has a 50 day moving average price of $16.15 and a two-hundred day moving average price of $13.22.
该股市值为8.2127亿美元,市盈率为-11.45,贝塔系数为1.12。该业务的50日移动均线价格为16.15美元,200日移动均线价格为13.22美元。
Insider Buying and Selling
内幕买卖
In related news, insider Darlene Noci sold 1,604 shares of the business's stock in a transaction dated Wednesday, August 24th. The stock was sold at an average price of $17.03, for a total value of $27,316.12. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, insider Darlene Noci sold 1,604 shares of the stock in a transaction that occurred on Wednesday, August 24th. The stock was sold at an average price of $17.03, for a total value of $27,316.12. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Matthew Shair sold 2,000 shares of the stock in a transaction that occurred on Friday, July 15th. The stock was sold at an average price of $18.29, for a total value of $36,580.00. Following the completion of the transaction, the director now directly owns 2,162,598 shares in the company, valued at approximately $39,553,917.42. The disclosure for this sale can be found here. Over the last three months, insiders have sold 24,386 shares of company stock worth $428,667. Corporate insiders own 15.79% of the company's stock.
在相关新闻中,内部人士Darlene Noci在一笔日期为8月24日星期三的交易中出售了1604股该公司股票。这只股票的平均售价为17.03美元,总价值为27,316.12美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过以下链接获得。在其他消息方面,内部人士Darlene Noci在8月24日星期三的一笔交易中出售了1604股该股。这只股票的平均售价为17.03美元,总价值为27,316.12美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,可以通过这个超级链接获得。此外,董事马修·夏尔在7月15日(星期五)的一次交易中出售了2,000股该股。这只股票的平均售价为18.29美元,总价值为36,580.00美元。交易完成后,董事现在直接拥有该公司2162,598股,价值约39,553,917.42美元。此次拍卖的披露信息可在此处找到。在过去的三个月里,内部人士已经出售了24,386股公司股票,价值428,667美元。公司内部人士持有该公司15.79%的股份。
Hedge Funds Weigh In On Nuvalent
对冲基金对Nuvalal的看法
Large investors have recently added to or reduced their stakes in the company. Strs Ohio raised its holdings in Nuvalent by 72.0% in the first quarter. Strs Ohio now owns 4,300 shares of the company's stock worth $59,000 after purchasing an additional 1,800 shares in the last quarter. California State Teachers Retirement System raised its holdings in Nuvalent by 35.0% in the first quarter. California State Teachers Retirement System now owns 7,811 shares of the company's stock worth $108,000 after purchasing an additional 2,024 shares in the last quarter. American International Group Inc. raised its holdings in Nuvalent by 59.8% in the first quarter. American International Group Inc. now owns 9,098 shares of the company's stock worth $126,000 after purchasing an additional 3,406 shares in the last quarter. New York State Common Retirement Fund raised its holdings in Nuvalent by 65.6% in the first quarter. New York State Common Retirement Fund now owns 12,922 shares of the company's stock worth $179,000 after purchasing an additional 5,120 shares in the last quarter. Finally, MetLife Investment Management LLC raised its holdings in Nuvalent by 196.6% in the first quarter. MetLife Investment Management LLC now owns 12,959 shares of the company's stock worth $180,000 after purchasing an additional 8,590 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.
大型投资者最近增持或减持了该公司的股份。俄亥俄州STRS在第一季度增持了72.0%的Nuvalal股份。STR俄亥俄州现在拥有该公司4300股股票,价值5.9万美元,上个季度又购买了1800股。加利福尼亚州教师退休制度在第一季度将其在Nuvalal的持有量增加了35.0%。加利福尼亚州教师退休系统现在拥有7811股该公司股票,价值10.8万美元,上个季度又购买了2024股。今年第一季度,美国国际集团(American International Group Inc.)将其在Nuvality的持股比例提高了59.8%。美国国际集团目前持有9,098股该公司股票,价值12.6万美元,该公司在上个季度又购买了3,406股。纽约州共同退休基金在第一季度增持了65.6%的Nuvalal股票。纽约州共同退休基金现在拥有12,922股该公司股票,价值179,000美元,上个季度又购买了5,120股。最后,大都会人寿投资管理有限责任公司在第一季度增持了196.6%的Nuvality股份。大都会人寿投资管理有限责任公司现在拥有12,959股该公司股票,价值18万美元,上个季度又购买了8,590股。95.07%的股票目前由机构投资者持有。
Nuvalent Company Profile
新价公司简介
(Get Rating)
(获取评级)
Nuvalent, Inc, a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial.
新价公司是一家临床阶段的生物制药公司,为癌症患者开发疗法。其主要候选产品有NVL-520,这是一种脑穿透性ROS1选择性抑制剂,用于抑制ROS1融合,这种融合表达正常的ROS1激活域,没有任何耐药突变,并且在存在对已批准和正在研究的ROS1抑制剂产生耐药性的突变时仍保持活性,该药处于I期开发中;以及NVL-655,一种脑渗透性ALK选择性抑制剂,用于解决紧急治疗耐药性、中枢神经系统相关不良事件和脑转移等临床挑战,这些挑战可能限制正在进行I/II期临床试验的第一、第二和第三代ALK抑制剂的使用。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Nuvalent (NUVL)
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
- 3 Low Beta Defensive Stocks for a Tough Market
- It Could Be a September to Remember for These 3 Stocks
- 免费获取StockNews.com关于Nuvalal的研究报告(NUVL)
- REV集团在电动汽车世界拥有深厚的护城河
- G-III服装集团有限公司是价值陷阱吗?
- 美国银行看好这两只欧洲酒类股票
- 3低贝塔防御性股票为艰难的市场做准备
- 对于这三只股票来说,这可能是一个值得记住的9月
Receive News & Ratings for Nuvalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvalent and related companies with MarketBeat.com's FREE daily email newsletter.
接受《新价日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对Nuvalal及相关公司评级的每日简要摘要。